{"id":"W4399381307","doi":"10.1200/jco.2024.42.16_suppl.tps4616","title":"Phase 3 study of disitamab vedotin with pembrolizumab vs chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Internal medicine; Urothelial cancer; Urothelial carcinoma; Cancer research; Cancer; Immunotherapy; Bladder cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00138423,0.001387786,0.002150335,0.0004492681,0.0004522441,0.001444633,0.0007885089,0.001457674,0.004220054],"category_scores_gemma":[0.0008473243,0.0005951838,0.001414716,0.0003869761,0.0008820578,0.001106591,0.0003594694,0.003456482,0.001045834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001446302,"about_ca_system_score_gemma":0.001559133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001468719,"about_ca_topic_score_gemma":0.003248345,"domain_scores_codex":[0.9996446,0.0001282776,0.00001301265,0.00007819944,0.00003112725,0.0001047415],"domain_scores_gemma":[0.9993697,0.00009087013,0.00009125477,0.00004966781,0.00003444854,0.0003640804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7719519,0.1083659,0.005406816,0.0005453982,0.001075928,0.0002643868,0.0003704243,0.002403558,0.03788731,0.0003523041,0.002826747,0.0685494],"study_design_scores_gemma":[0.326076,0.6537939,0.01096169,0.00003481733,0.0004367378,0.0002621007,0.00009212991,0.001360961,0.00331099,0.0002588965,0.003382673,0.00002913491],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929419,0.001800892,0.000390808,0.0003400058,0.0001599886,0.001925433,0.0008189508,0.00006112782,0.001560951],"genre_scores_gemma":[0.9902581,0.001251748,0.001053429,0.0007162372,0.0001676264,0.002379951,0.001545653,0.0000279159,0.002599398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004220054,"threshold_uncertainty_score":0.01411754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05838603961958719,"score_gpt":0.4192842945473096,"score_spread":0.3608982549277224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}